Epoxyeicosatrienoic Acids (EETs) and Soluble Epoxide Hydrolase (sEH):A Journey from Physiology to Clinical Trials: GSBS Guest Speaker Dr. John Imig (December 4, 2019)

 

Epoxyeicosatrienoic Acids (EETs) and Soluble Epoxide Hydrolase (sEH):A Journey from Physiology to Clinical Trials: GSBS Guest Speaker Dr. John Imig (December 4, 2019)

Seminar Location: IREB-230 beginning at 10:00 am

John D. Imig is an accomplished scientist focused on cardiovascular and kidney diseases. He received his BA in Biology from Blackburn College and a PhD in Physiology and Biophysics from the University of Louisville. John has been a faculty member at the Tulane University School of Medicine and the Medical College of Georgia before joining the Medical College of Wisconsin in 2008. Dr. Imig has demonstrated that a research laboratory can make significant basic science breakthroughs while also developing promising new drugs.

Throughout his career, Dr. Imig has emphasized scholarship through the publication of approximately 225 articles, original papers, editorials and reviews, and has presented approximately 90 national and international lectures and workshops. He holds four patents and has a number of other pending patent applications. John has successfully worked with biotechnology companies through research and licensing agreements to move drugs forward into clinical trials. Dr. Imig has received a number of distinguished awards including the Established Investigator Award and Lewis K. Dahl Memorial Lectureship from the American Heart Association and being named a Medical College of Wisconsin Eminent Scholar. John is currently funded by the National Institutes of Health, Wisconsin Economic Development Commission, and the Dr. Ralph and Marian Falk Medical Research Trust.

The Imig laboratory is dedicated to understanding how certain fatty acids, known as eicosanoids, influence kidney and cardiovascular function. His team has advanced its findings through translational research and developed new eicosanoid-based drugs to potentially treat diseases including hypertension, stroke, heart attacks, diabetes, and kidney diseases.

“Molecular determinants of West Nile virus virulence and antigenicity.” GSBS Guest Speaker David Beasley, Ph.D. December 3, 2019

 

GSBS guest speaker David Beasley, Ph.D., presents results Molecular determinants of West Nile virus virulence and antigenicity.

Seminar Location: LIB-110 beginning at 10:00 am on December 3, 2019

Dr. David Beasley received a PhD in Life Sciences from the Queensland University of Technology, Brisbane, Australia in 1999 and is a Professor in the Department of Microbiology and Immunology at the University of Texas Medical Branch (UTMB) in Galveston, Texas. Research in his laboratory focuses on the molecular basis of virulence and antigenic variations between strains of West Nile virus and other flaviviruses. His lab’s wider research activities include studies related to the development of improved diagnostic and therapeutic reagents and vaccines for flaviviruses and other arboviruses. Dr. Beasley is the Director of Regulatory and Scientific Affairs for UTMB’s Institutional Office of Regulated Nonclinical Studies where he oversees the implementation and operation of GLP-based quality systems to facilitate conduct of animal model development and efficacy studies at ABSL3/ABSL4 necessary to support future licensure of medical countermeasures for bio-defense and emerging disease agents under the FDA’s Animal Rule. He also serves as a member of the Executive Committee of UTMB’s Sealy Institute for Vaccine Sciences, is the Associate Director of the World Health Organization Collaborating Center on Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, and is a former Co-Director of UTMB’s select agent BSL3 laboratories.

Super Resolution Confocal Training opportunity on 12/9/19

 

This is an opportunity to have lab members participate in our monthly training session on the Inverted Zeiss LSM 880 AiryScan Microscope (Super resolution image capture capability). For information on the microscope check out our Microscopy Core Facility Website-
https://www.unthsc.edu/research/microscopy-core-facility/equipment/light-microscopy-resources/

This training session will be held on December 9th, 2019 at 2:00 PM. We have 2 spots left for trainees. It will be at 2.5-hour session and the charge will be $40 per person.
Once this training session has been completed, trainees will be able to use the microscope with assistance ($65/hour) until they have demonstrated an appropriate level of proficiency in the use of this microscope. Then they will be able to use the microscope independently at a charge of $35/hour.

Training will be offered monthly so if you don’t need training right away, look out for further announcements in the Daily News and on the core webpage https://www.unthsc.edu/research/microscopy-core-facility/.

Please email Kishor.Kunwar@UNTHSC.edu with further questions or with the names and email addresses of the lab members you wish to participate in this training session along with the chart string to cover the training session charges.”

TCU and UNTHSC School of Medicine’s Annual Health Care Forum

 

Annual Health Care Forum
Presented by: TCU Health Care MBA and the TCU and UNTHSC School of Medicine
A Healthy Bottom Line: What Matters to Patients?
A nationally recognized panel of industry experts offer perspectives on engaging and communicating with today’s health care consumers.
*Must Register to attend*

TCU and UNTHSC School of Medicine Annual Health Care Forum

 

Annual Health Care Forum
Presented by: TCU Health Care MBA and the TCU and UNTHSC School of Medicine
A Healthy Bottom Line: What Matters to Patients?
A nationally recognized panel of industry experts offer perspectives on engaging and communicating with today’s health care consumers.
*Must Register to attend*

TCU and UNTHSC School of Medicine’s Annual Health Care Forum

 

Annual Health Care Forum
Presented by: TCU Health Care MBA and the TCU and UNTHSC School of Medicine
A Healthy Bottom Line: What Matters to Patients?
A nationally recognized panel of industry experts offer perspectives on engaging and communicating with today’s health care consumers.

*Must register to attend*

Career Advising Open Hours – CV/Resume/Personal Statement Reviews and Career Questions

 

Meet with Donna Gill, Career Center Intern (Master of Science in Counseling at SMU) for a CV/Resume/Personal Statement review or ask a quick question about careers/internships. Walk-ins welcome or RSVP by emailing the Career Center at careercenter@unthsc.edu.

“Molecular determinants of West Nile virus virulence and antigenicity.” GSBS Guest Speaker David Beasley, Ph.D. December 3, 2019

 

GSBS guest speaker David Beasley, Ph.D., presents results Molecular determinants of West Nile virus virulence and antigenicity.

Seminar Location: LIB-110 beginning at 10:00 am on December 3, 2019

Dr. David Beasley received a PhD in Life Sciences from the Queensland University of Technology, Brisbane, Australia in 1999 and is a Professor in the Department of Microbiology and Immunology at the University of Texas Medical Branch (UTMB) in Galveston, Texas. Research in his laboratory focuses on the molecular basis of virulence and antigenic variations between strains of West Nile virus and other flaviviruses. His lab’s wider research activities include studies related to the development of improved diagnostic and therapeutic reagents and vaccines for flaviviruses and other arboviruses. Dr. Beasley is the Director of Regulatory and Scientific Affairs for UTMB’s Institutional Office of Regulated Nonclinical Studies where he oversees the implementation and operation of GLP-based quality systems to facilitate conduct of animal model development and efficacy studies at ABSL3/ABSL4 necessary to support future licensure of medical countermeasures for bio-defense and emerging disease agents under the FDA’s Animal Rule. He also serves as a member of the Executive Committee of UTMB’s Sealy Institute for Vaccine Sciences, is the Associate Director of the World Health Organization Collaborating Center on Vaccine Research, Evaluation and Training on Emerging Infectious Diseases, and is a former Co-Director of UTMB’s select agent BSL3 laboratories.

Epoxyeicosatrienoic Acids (EETs) and Soluble Epoxide Hydrolase (sEH):A Journey from Physiology to Clinical Trials: GSBS Guest Speaker Dr. John Imig (December 4, 2019)

 

Epoxyeicosatrienoic Acids (EETs) and Soluble Epoxide Hydrolase (sEH):A Journey from Physiology to Clinical Trials: GSBS Guest Speaker Dr. John Imig (December 4, 2019)

Seminar Location: IREB-230 beginning at 10:00 am

John D. Imig is an accomplished scientist focused on cardiovascular and kidney diseases. He received his BA in Biology from Blackburn College and a PhD in Physiology and Biophysics from the University of Louisville. John has been a faculty member at the Tulane University School of Medicine and the Medical College of Georgia before joining the Medical College of Wisconsin in 2008. Dr. Imig has demonstrated that a research laboratory can make significant basic science breakthroughs while also developing promising new drugs.

Throughout his career, Dr. Imig has emphasized scholarship through the publication of approximately 225 articles, original papers, editorials and reviews, and has presented approximately 90 national and international lectures and workshops. He holds four patents and has a number of other pending patent applications. John has successfully worked with biotechnology companies through research and licensing agreements to move drugs forward into clinical trials. Dr. Imig has received a number of distinguished awards including the Established Investigator Award and Lewis K. Dahl Memorial Lectureship from the American Heart Association and being named a Medical College of Wisconsin Eminent Scholar. John is currently funded by the National Institutes of Health, Wisconsin Economic Development Commission, and the Dr. Ralph and Marian Falk Medical Research Trust.

The Imig laboratory is dedicated to understanding how certain fatty acids, known as eicosanoids, influence kidney and cardiovascular function. His team has advanced its findings through translational research and developed new eicosanoid-based drugs to potentially treat diseases including hypertension, stroke, heart attacks, diabetes, and kidney diseases.

Healthy volunteers 18-40

 

unthsc.edu/romerolab
The University of North Texas Health Science Center and the Human Vascular Physiology Laboratory are recruiting up to 20 subjects (male and female) to take part in a study that will determine if tauroursodeoxycholic acid (TUDCA) supplementation alters vascular function following forearm ischemia-reperfusion in young healthy humans.
You must be:
• 18-40 years old; males & females
• Generally healthy
• Currently a non-tobacco/nicotine user (cigarettes, e-cigarettes, chewing tobacco, nicotine patch/gum)
Study Requirements:
• Visit Human Vascular Physiology Laboratory at UNTHSC on 3 separate days; the first will be 1-2 hours, the second and third will be 2 – 3.5 hours
• Participation in this study is voluntary, and if you are a student or employee of UNTHSC your participation (or non-participation) in this study will in no way affect your academic standing or employment.
• Subjects will be compensated for their time and effort.

If you are interested in participating in this study as a research subject, please contact Amy Moore via email (amy.moore@unthsc.edu) or phone (817-735-2088).